The Medical University of Vienna is a public university located in Vienna, Austria. It is the direct successor to the faculty of medicine at the University of Vienna, founded in 1365 by Rudolf IV, Duke of Austria.

During the past decade, Department of Clinical Pharmacology, Medical University of Vienna conducted 58 clinical trials. In the 10-year time frame, 58 clinical trials started and 6 clinical trials were completed, i.e. on average, 10.3% percent of trials that started reached the finish line to date. In the past 5 years, 14 clinical trials started and 5 clinical trials were completed. i.e. 35.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Department of Clinical Pharmacology, Medical University of Vienna" #1 sponsor was "Medical University of Vienna" with 126 trials, followed by "Glock Health, Science and Research GmbH" with 4 trials sponsored, "Gerhard Garhofer" with 3 trials sponsored, "AVIR Green Hills Biotechnology AG" with 2 trials sponsored and "Affiris AG" with 2 trials sponsored. Other sponsors include 17 different institutions and companies that sponsored additional 23 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Department of Clinical Pharmacology, Medical University of Vienna" #1 collaborator was "Medical University of Vienna" with 4 trials as a collaborator, "Croma-Pharma GmbH" with 2 trials as a collaborator, "Aprofol AG" with 1 trials as a collaborator, "Aston University" with 1 trials as a collaborator and "Baxter Innovations GmbH" with 1 trials as a collaborator. Other collaborators include 3 different institutions and companies that were collaborators in the rest 13 trials.

According to Clinical.Site data, the most researched conditions in "Department of Clinical Pharmacology, Medical University of Vienna" are "Healthy" (22 trials), "Regional Blood Flow" (20 trials), "Ocular Physiology" (16 trials), "Dry Eye Syndromes" (10 trials) and "Glaucoma" (10 trials). Many other conditions were trialed in "Department of Clinical Pharmacology, Medical University of Vienna" in a lesser frequency.

Most popular intervention types in "Department of Clinical Pharmacology, Medical University of Vienna" are "Drug" (69 trials), "Device" (47 trials), "Other" (32 trials), "Procedure" (19 trials) and "Biological" (11 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (23 trials), "Dynamic Vessel Analyzer (DVA)" (6 trials), "Goldmann applanation tonometer" (6 trials), "Optical coherence tomography (OCT)" (5 trials) and "Dynamic Vessel Analyzer" (4 trials). Other intervention names were less common.

The vast majority of trials in "Department of Clinical Pharmacology, Medical University of Vienna" are 116 trials for "All" genders, 41 trials for "Male" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Department of Clinical Pharmacology, Medical University of Vienna". undefined are not yet recruiting, 19 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 112 completed trials in Department of Clinical Pharmacology, Medical University of Vienna, undefined suspended trials, and 12 terminated clinical trials to date.

Out of the total trials that were conducted in Department of Clinical Pharmacology, Medical University of Vienna, 19 "Phase 1" clinical trials were conducted, 20 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 25 trials, and there were also 70 trials that are defined as “Not Applicable".